firmagon
(Degarelix)Ferring Pharmaceuticals Inc.
Usage: FIRMAGON® is indicated for the treatment of patients with advanced prostate cancer.
Gonadotropin Releasing Hormone Receptor Antagonist class drugs
5 results
myfembree
(relugolix, estradiol hemihydrate, and norethindrone acetate)Sumitomo Pharma America, IncUsage: MYFEMBREE is indicated for managing heavy menstrual bleeding due to uterine leiomyomas and for moderate to severe pain associated with endometriosis in premenopausal women. Its use should be limited to 24 months to mitigate the risk of irreversible bone loss.orgovyx
(relugolix)Sumitomo Pharma America, IncUsage: ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer.oriahnn
(Elagolix and Estradiol and Norethisterone)AbbVie Inc.Usage: ORIAHNN is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. Use is limited to 24 months due to the risk of potential irreversible bone loss.orilissa
(Elagolix)AbbVie Inc.Usage: ORILISSA is indicated for managing moderate to severe pain related to endometriosis. Use duration should be limited based on dosage and the patient's coexisting conditions.